Clinical Trials - BCYC

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06933329Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung CancerRECRUITINGPHASE22025-07-182029-02-282028-08-31
NCT06840483Study of Zelenectide Pevedotin in Participants With Advanced Breast CancerRECRUITINGPHASE22025-03-032028-12-302028-06-30
NCT06225596Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)RECRUITINGPHASE2, PHASE32024-01-242030-122030-12
NCT05163041Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 ExpressionACTIVE_NOT_RECRUITINGPHASE1, PHASE22021-11-022025-122025-09
NCT04561362Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesRECRUITINGPHASE1, PHASE22020-07-172026-122026-03
NCT04180371Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionRECRUITINGPHASE1, PHASE22019-11-072025-10-012025-10-01